Table 3.
Cardiometabolic risk marker values in SIT and WALK. Data are presented as median (minimum–maximum).
| SIT | WALK | |
|---|---|---|
| Fasting glucose (mmol/L) | 5.0 (3.9–6.2) | 5.1 (3.8–5.9) |
| Fasting insulin (μU/mL) | 7.7 (4.2–8.9) | 7.3 (5.0–11.9) |
| Fasting TG (mmol/L) | 0.8 (0.6–1.0) | 0.8 (0.6–1.1) |
| tAUC glucose (mmol/L.5-h) | 29.5 (23.4–34.2) | 25.6 (18.5–38.1) |
| Net iAUC glucose (mmol/L.5-h) | 3.2 (-5.7–13.0) | 0.30 (-2.2–12.2) |
| Positive iAUC glucose (mmol/L.5-h) | 3.2 (0.7–13.4) | 2.0 (0.1–12.6) |
| tAUC insulin (μU/mL.5-h) | 86.1 (174.5–421.6) | 70.8 (113.0–294.7)∗ |
| Net iAUC insulin (μU/mL.5-h) | 82.6 (453.6–381.4) | 65.9 (68.4–251.3)∗ |
| Positive iAUC insulin (μU/mL.5-h) | 82.6 (153.6–382.8) | 59.5 (68.4–250.9)∗ |
| tAUC TG (mmol/L.5-h) | 1.0 (3.2–6.6) | 1.2 (2.6–6.4)∗ |
| Net iAUC TG (mmol/L.5-h) | 0.8 (0.4–2.8) | 0.5 (-0.3–1.6)∗ |
| Positive iAUC TG (mmol/L.5-h) | 1.1 (0.4–2.8) | 0.7 (0.0–5.5)∗ |
∗ significant difference between WALK and SIT (p < 0.01); SIT, uninterrupted sitting; WALK, breaking up sitting with walking; TG, triglycerides; tAUC, total area under the curve; iAUC, incremental area under the curve.